Effect of sarpogrelate on monocrotaline-induced experimental pulmonary artery hypertension and NFAT3 expression in pulmonary artery

韩俊丽,田红燕,迟丽屹,刘亚,王文平,吕颖,闫晓丽,张再伟,田华
DOI: https://doi.org/10.3969/J.ISSN.1007-6611.2013.09.003
2013-01-01
Abstract:Objective To explore the effect of sarpogrelate on monocrotaline-induced experimental pulmonary artery hypertension and NFAT3 expression in pulmonary artery.Methods The rats were divided into control group(n = 6),model group(n = 6) and sarpogrelate group(n = 6).Pulmonary artery hypertension rat model was induced by intraperitoneal injection of monocrotaline(MCT).The model rats were daily given oral sarpogrelate(100mg / kg) for 4 weeks in sarpogrelate group.Pulmonary artery pressure was measured and right heart ratio was calculated.Pulmonary artery remodeling was evaluated by HE staining.NFAT3 protein level was measured by Western blot.Results Compared with model group,pulmonary artery pressure,right heart ratio and pulmonary artery remodeling decreased in sarpogrelate group(P < 0.05),and NFAT3 protein expression in pulmonary artery was also decreased(P < 0.05).Conclusion Sarpogrelate could improve the pulmonary artery hypertension in MCT-induced model and decrease the upregulated NFAT3 protein expression in pulmonary artery.
What problem does this paper attempt to address?